Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2900268 | 0.98 | GABRA1 (0.40) | GABRA1GABRG2GABRB3TSHRGABRB2 | |
| Hydrochloric Acid SCHEMBL818414 | 0.98 | GABRA1 (0.40) | GABRA1GABRG2GABRB3TSHRGABRB2 | |
| Bromide SCHEMBL2895695 | 0.98 | GABRA1 (0.40) | GABRA1GABRG2GABRB3TSHRGABRB2 | |
| SCHEMBL15826554 | 0.82 | FAAH (0.43) | GABRA1GABRG2GABRB3TSHRGABRB2 | |
| SCHEMBL760008 | 0.82 | LMNA (0.40) | GABRA1GABRG2GABRB3TSHRGABRB2 | |
| SCHEMBL30265954 | 0.82 | FAAH (0.43) | GABRA1GABRG2GABRB3TSHRGABRB2 | |
| SCHEMBL23344386 | 0.76 | GABRA1 (0.35) | GABRA1GABRG2GABRB3TSHRGABRB2 | |
| SCHEMBL21036086 | 0.76 | ANPEP (0.41) | GABRA1GABRG2GABRB3TSHRGABRB2 | |
| SCHEMBL2523158 | 0.76 | GABRA1 (0.35) | GABRA1GABRG2GABRB3TSHRGABRB2 | |
| Hydrochloric Acid SCHEMBL2528008 | 0.74 | TSHR (0.34) | GABRA1GABRG2GABRB3TSHRGABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197983-A1 | METHOD FOR THE PRODUCTION OF UNBRANCHED ACYCLIC OCTACTRIENES | OXENO OLEFINCHEMIE GMBH (DE) | 2010-08-05 | — | — | US | claimed |
| EP-1824802-B1 | METHOD FOR THE PRODUCTION OF UNBRANCHED ACYCLIC OCTACTRIENES | EVONIK OXENO GMBH (DE) | 2009-06-17 | — | — | EP | claimed |
| US-9309344-B2 | Process for preparing polymers by means of ring-opening polymerization | EVONIK DEGUSSA GMBH (DE) | 2016-04-12 | — | — | US | disclosed |
| US-20160031845-A1 | IN-SITU GENERATION OF RUTHENIUM CATALYSTS FOR OLEFIN METATHESIS | EVONIK DEGUSSA GMBH (DE) | 2016-02-04 | — | — | US | disclosed |
| US-20150299362-A1 | PROCESS FOR PREPARING POLYMERS BY MEANS OF RING-OPENING POLYMERIZATION | EVONIK INDUSTRIES AG (DE) | 2015-10-22 | — | — | US | disclosed |
| EP-2933274-A1 | Method for the production of polymers by means of ring-opening polymerisation | Evonik Degussa GmbH (DE) | 2015-10-21 | — | — | EP | disclosed |
| US-20150005457-A1 | ANTIMICROBIAL SURFACE MODIFIED SILICONE RUBBER AND METHODS OF PREPARATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2015-01-01 | — | — | US | disclosed |
| EP-2574187-A1 | SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME | Amyris Biotechnologies, Inc. (US) | 2013-04-03 | — | — | EP | disclosed |
| WO-2011146837-A1 | SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME | Amyris, Inc. (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20100197983-A1 | METHOD FOR THE PRODUCTION OF UNBRANCHED ACYCLIC OCTACTRIENES | OXENO OLEFINCHEMIE GMBH (DE) | 2010-08-05 | — | — | US | disclosed |
| US-20100197983-A1 | METHOD FOR THE PRODUCTION OF UNBRANCHED ACYCLIC OCTACTRIENES | OXENO OLEFINCHEMIE GMBH (DE) | 2010-08-05 | — | — | US | disclosed |
| US-20100197983-A1 | METHOD FOR THE PRODUCTION OF UNBRANCHED ACYCLIC OCTACTRIENES | OXENO OLEFINCHEMIE GMBH (DE) | 2010-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197983-A1 | METHOD FOR THE PRODUCTION OF UNBRANCHED ACYCLIC OCTACTRIENES | JUN, OXER1, OSTC | GABRA1 1321/4885GABRG2 1778/4885GABRB3 884/4885 |
| US-20160031845-A1 | IN-SITU GENERATION OF RUTHENIUM CATALYSTS FOR OLEFIN METATHESIS | LOXL2, MLX, MCOLN2 | GABRA1 3929/4885GABRG2 4344/4885GABRB3 4426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.